AKT1(low) quiescent cancer cells persist after neoadjuvant chemotherapy in triple negative breast cancer

BACKGROUND: Absence of pathologic complete response (pCR) to neoadjuvant chemotherapy (NACT) correlates with poor long-term survival in patients with triple negative breast cancer (TNBC). These incomplete treatment responses are likely determined by mechanisms that enable cancer cells to resist bein...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Breast Cancer Res
Main Authors: Kabraji, Sheheryar, Solé, Xavier, Huang, Ying, Bango, Clyde, Bowden, Michaela, Bardia, Aditya, Sgroi, Dennis, Loda, Massimo, Ramaswamy, Sridhar
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5540189/
https://ncbi.nlm.nih.gov/pubmed/28764807
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-017-0877-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados